サマリー

勃起不全（ED）は、インポテンツとしても知られており、性行為中に陰茎を勃起させることができない、または維持することができないことを特徴とする性機能障害の一種です。勃起不全は、人間関係の問題や自己イメージに結びつくため、心理的な影響を与えることがあります。

市場分析と洞察。世界および米国のED治療薬市場
当レポートでは、世界および米国のED治療薬市場に焦点を当てています。
2020年の世界のED治療市場規模はXX百万米ドルで、2021-2027年の間にXX％のCAGRで、2027年末にXX百万米ドルに達すると予想されています。米国では、ED治療の市場規模は2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予測されています。

世界のED治療の範囲と市場規模
ED治療市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のED治療市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの地域（国）別、タイプ別、アプリケーション別の収益と予測に焦点を当てています。
米国市場では、2016-2027年のED治療薬の市場規模をプレイヤー別、タイプ別、アプリケーション別に分析しています。主要なプレイヤーには、アメリカ合衆国で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
Sildenafil（シルデナフィル
Tadalafil（タダラフィル
その他

用途別セグメント
病院
ドラッグストア
その他

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

会社別
Eli Lilly
ファイザー
バイエル
BaiYunShan General Factory
S.K. Chemicals
テバファーマ
東亜ST
メッチェンファーマ
ソウルファーマ
CSBIO

ページTOPに戻る

目次

1 Study Coverage
1.1 ED Treatment Product Introduction
1.2 Market by Type
1.2.1 Global ED Treatment Market Size Growth Rate by Type
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Market by Application
1.3.1 Global ED Treatment Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global ED Treatment Market Size, Estimates and Forecasts
2.1.1 Global ED Treatment Revenue 2016-2027
2.1.2 Global ED Treatment Sales 2016-2027
2.2 Global ED Treatment, Market Size by Region: 2016 VS 2021 VS 2027
2.3 ED Treatment Historical Market Size by Region (2016-2021)
2.3.1 Global ED Treatment Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global ED Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 ED Treatment Market Estimates and Projections by Region (2022-2027)
2.4.1 Global ED Treatment Sales Forecast by Region (2022-2027)
2.4.2 Global ED Treatment Revenue Forecast by Region (2022-2027)

3 Global ED Treatment Competitor Landscape by Players
3.1 Global Top ED Treatment Manufacturers by Sales
3.1.1 Global ED Treatment Sales by Manufacturer (2016-2021)
3.1.2 Global ED Treatment Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top ED Treatment Manufacturers by Revenue
3.2.1 Key ED Treatment Manufacturers Covered: Ranking by Revenue
3.2.2 Global ED Treatment Revenue by Manufacturers (2016-2021)
3.2.3 Global ED Treatment Revenue Share by Manufacturers (2016-2021)
3.2.4 Global ED Treatment Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by ED Treatment Revenue in 2020
3.2.6 Global ED Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global ED Treatment Price by Manufacturers
3.4 Global ED Treatment Manufacturing Base Distribution, Product Types
3.4.1 ED Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers ED Treatment Product Type
3.4.3 Date of International Manufacturers Enter into ED Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global ED Treatment Market Size by Type (2016-2021)
4.1.1 Global ED Treatment Sales by Type (2016-2021)
4.1.2 Global ED Treatment Revenue by Type (2016-2021)
4.1.3 ED Treatment Average Selling Price (ASP) by Type (2016-2021)
4.2 Global ED Treatment Market Size Forecast by Type (2022-2027)
4.2.1 Global ED Treatment Sales Forecast by Type (2022-2027)
4.2.2 Global ED Treatment Revenue Forecast by Type (2022-2027)
4.2.3 ED Treatment Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global ED Treatment Market Size by Application (2016-2021)
5.1.1 Global ED Treatment Sales by Application (2016-2021)
5.1.2 Global ED Treatment Revenue by Application (2016-2021)
5.1.3 ED Treatment Price by Application (2016-2021)
5.2 ED Treatment Market Size Forecast by Application (2022-2027)
5.2.1 Global ED Treatment Sales Forecast by Application (2022-2027)
5.2.2 Global ED Treatment Revenue Forecast by Application (2022-2027)
5.2.3 Global ED Treatment Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
6.1 United States ED Treatment Market Size YoY Growth 2016-2027
6.1.1 United States ED Treatment Sales YoY Growth 2016-2027
6.1.2 United States ED Treatment Revenue YoY Growth 2016-2027
6.1.3 United States ED Treatment Market Share in Global Market 2016-2027
6.2 United States ED Treatment Market Size by Players (International and Local Players)
6.2.1 United States Top ED Treatment Players by Sales (2016-2021)
6.2.2 United States Top ED Treatment Players by Revenue (2016-2021)
6.3 United States ED Treatment Historic Market Review by Type (2016-2021)
6.3.1 United States ED Treatment Sales Market Share by Type (2016-2021)
6.3.2 United States ED Treatment Revenue Market Share by Type (2016-2021)
6.3.3 United States ED Treatment Price by Type (2016-2021)
6.4 United States ED Treatment Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States ED Treatment Sales Forecast by Type (2022-2027)
6.4.2 United States ED Treatment Revenue Forecast by Type (2022-2027)
6.4.3 United States ED Treatment Price Forecast by Type (2022-2027)
6.5 United States ED Treatment Historic Market Review by Application (2016-2021)
6.5.1 United States ED Treatment Sales Market Share by Application (2016-2021)
6.5.2 United States ED Treatment Revenue Market Share by Application (2016-2021)
6.5.3 United States ED Treatment Price by Application (2016-2021)
6.6 United States ED Treatment Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States ED Treatment Sales Forecast by Application (2022-2027)
6.6.2 United States ED Treatment Revenue Forecast by Application (2022-2027)
6.6.3 United States ED Treatment Price Forecast by Application (2022-2027)

7 North America
7.1 North America ED Treatment Market Size YoY Growth 2016-2027
7.2 North America ED Treatment Market Facts & Figures by Country
7.2.1 North America ED Treatment Sales by Country (2016-2021)
7.2.2 North America ED Treatment Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific ED Treatment Market Size YoY Growth 2016-2027
8.2 Asia Pacific ED Treatment Market Facts & Figures by Region
8.2.1 Asia Pacific ED Treatment Sales by Region (2016-2021)
8.2.2 Asia Pacific ED Treatment Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe ED Treatment Market Size YoY Growth 2016-2027
9.2 Europe ED Treatment Market Facts & Figures by Country
9.2.1 Europe ED Treatment Sales by Country (2016-2021)
9.2.2 Europe ED Treatment Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America ED Treatment Market Size YoY Growth 2016-2027
10.2 Latin America ED Treatment Market Facts & Figures by Country
10.2.1 Latin America ED Treatment Sales by Country (2016-2021)
10.2.2 Latin America ED Treatment Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa ED Treatment Market Size YoY Growth 2016-2027
11.2 Middle East and Africa ED Treatment Market Facts & Figures by Country
11.2.1 Middle East and Africa ED Treatment Sales by Country (2016-2021)
11.2.2 Middle East and Africa ED Treatment Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Corporation Information
12.1.2 Eli Lilly Description and Business Overview
12.1.3 Eli Lilly ED Treatment Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Eli Lilly ED Treatment Products Offered
12.1.5 Eli Lilly Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer ED Treatment Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer ED Treatment Products Offered
12.2.5 Pfizer Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Description and Business Overview
12.3.3 Bayer ED Treatment Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer ED Treatment Products Offered
12.3.5 Bayer Recent Development
12.4 BaiYunShan General Factory
12.4.1 BaiYunShan General Factory Corporation Information
12.4.2 BaiYunShan General Factory Description and Business Overview
12.4.3 BaiYunShan General Factory ED Treatment Sales, Revenue and Gross Margin (2016-2021)
12.4.4 BaiYunShan General Factory ED Treatment Products Offered
12.4.5 BaiYunShan General Factory Recent Development
12.5 S.K. Chemicals
12.5.1 S.K. Chemicals Corporation Information
12.5.2 S.K. Chemicals Description and Business Overview
12.5.3 S.K. Chemicals ED Treatment Sales, Revenue and Gross Margin (2016-2021)
12.5.4 S.K. Chemicals ED Treatment Products Offered
12.5.5 S.K. Chemicals Recent Development
12.6 Teva Pharma
12.6.1 Teva Pharma Corporation Information
12.6.2 Teva Pharma Description and Business Overview
12.6.3 Teva Pharma ED Treatment Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teva Pharma ED Treatment Products Offered
12.6.5 Teva Pharma Recent Development
12.7 Dong-A ST
12.7.1 Dong-A ST Corporation Information
12.7.2 Dong-A ST Description and Business Overview
12.7.3 Dong-A ST ED Treatment Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Dong-A ST ED Treatment Products Offered
12.7.5 Dong-A ST Recent Development
12.8 Metuchen Pharma
12.8.1 Metuchen Pharma Corporation Information
12.8.2 Metuchen Pharma Description and Business Overview
12.8.3 Metuchen Pharma ED Treatment Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Metuchen Pharma ED Treatment Products Offered
12.8.5 Metuchen Pharma Recent Development
12.9 Seoul Pharma
12.9.1 Seoul Pharma Corporation Information
12.9.2 Seoul Pharma Description and Business Overview
12.9.3 Seoul Pharma ED Treatment Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Seoul Pharma ED Treatment Products Offered
12.9.5 Seoul Pharma Recent Development
12.10 CSBIO.
12.10.1 CSBIO. Corporation Information
12.10.2 CSBIO. Description and Business Overview
12.10.3 CSBIO. ED Treatment Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CSBIO. ED Treatment Products Offered
12.10.5 CSBIO. Recent Development
12.11 Eli Lilly
12.11.1 Eli Lilly Corporation Information
12.11.2 Eli Lilly Description and Business Overview
12.11.3 Eli Lilly ED Treatment Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Eli Lilly ED Treatment Products Offered
12.11.5 Eli Lilly Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 ED Treatment Industry Trends
13.2 ED Treatment Market Drivers
13.3 ED Treatment Market Challenges
13.4 ED Treatment Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 ED Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer